Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
66 Cards in this Set
- Front
- Back
Block cell wall synthesis by inhibition of peptidoglycan cross-linking
|
Penicillin, ampicillin, ticarcillin, piperacillin, imipenem, aztreonam, cephalosporins
|
|
Block peptidoglycan synthesis
|
Bacitracin and vancomycin
|
|
Disrupt bacterial cell membranes
|
Polymyxins and daptomycin
|
|
Block nucleotide synthesis
|
Sulfonamides and trimethoprim
|
|
Block DNA topoisomerases
|
Fluoroquinolones
|
|
Block mRNA synthesis
|
Rifampin
|
|
Block protein sythesis at 50S ribosomal subunit
|
Chloramphenicol, macrolides, clindamycin, streptogramins (quinupristin, dalfopristin), linezolid, daptomycin
|
|
Macrolides
|
Erythromycin, clarithromycin, azithromycin
|
|
Block protein synthesis at 30S ribosomal subunit
|
Aminoglycosides, tetracyclines
|
|
Aminoglycosides (5)
|
Streptomycin, Gentamicin, Tobramycin, Amikacin, Neomycin
|
|
Tetracyclines (4)
|
Tetracycline, doxycycline, minocycline, tigecycline
|
|
Aminoglycosides good against
|
Gram negative aerobic infections
|
|
Aminoglycosides a DOC for these 3
|
Pseudomonas, Invasive enterococcal infections, Francisella tularensis
|
|
2 things that block the transport of Aminoglycosides
|
Anaerobic environment and low extracellular pH
|
|
Most common Aminoglycosides resistance mechanism
|
Aminoglycoside modifying enzymes (AME)
|
|
Aminoglycosides: IV or parenterally
|
Usually given parenterally unless local GI effect desired
|
|
How are aminoglycosides eliminated?
|
Largely eliminated by the kidneys; must adjust dose relative to creatinine clearance
|
|
Primary toxicities of Aminoglycosides
|
Nephrotoxicity, Ototoxicity, and Neuromuscular blockade
|
|
Absolute contraindication for aminoglycosides
|
Myasthenia gravis - high risk of neuromuscular blockade causing respiratory depression
|
|
How to reverse the neuromuscular blockade caused by aminoglycosides
|
Calcium gluconate or neostigmine
|
|
Can be used alone to treat tularemia and plague
|
Streptomycin
|
|
Drugs to treat brucellosis
|
Streptomycin and doxycycline
|
|
Used in combination with a cillin for Pseudomonas or Enterococcal; most frequently used AG
|
Gentamicin
|
|
Used when other Aminoglycosides fail; has the broadest spectrum
|
Amikacin
|
|
Primarily used orally to sterilize the gut; when taken systemically is the most toxic of the Aminoglycosides
|
Neomycin
|
|
The 4 tetracyclines
|
Tetracycline, doxycycline, minocycline, tigecycline
|
|
Preferred tetracycline for patients with poor renal function
|
Doxycycline
|
|
Preferred tetracycline for meningococcal carrier state (enters CSF in therapeutic amounts)
|
Minocycline
|
|
Drug of choice for Bacillus anthracis
|
Tetracyclines
|
|
Drug of choice for Mycoplasma p., chlamydia, Rickettsiae, Lyme disease
|
Tetracyclines
|
|
Tetracyclines: bacteriocidal or -static
|
Bacteriostatic
|
|
Primary resistance to tetracyclines via:
|
Efflux pumps and ribosome protection
|
|
Form stable 'chelates' with cations
|
Tetracyclines
|
|
Tetracycline given IV, with biliary excretion, and effective against resistant organisms (MRSA, etc)
|
Tigecycline
|
|
6 adverse reactions to tetracyclines
|
Gastrointestinal, Bony structures and teeth, liver toxicity, local tissue toxicity, photosensitization, vestibular reactions
|
|
Outdated and degraded tetracyclines can cause this if taken
|
Fanconi syndrome
|
|
50S inhibitor that can cause bone marrow suppression and serious and fatal blood dyscrasias
|
Chloramphenicol
|
|
Gray syndrome
|
Adverse effect of Chloramphenicol caused by a lack of glucuronyl transferase activity
|
|
Drug of choice for Campylocbacter jejuni, H. pylori, Shiggella spp
|
Macrolides
|
|
Drug of choice for children and pregnant females or allergic to penicillin
|
Macrolides
|
|
Macrolides: bacteriocidal or bacteriostatic
|
Bacteriostatic
|
|
Resistance to Macrolides via:
|
Active efflux pump and Ribosome modification
|
|
Less frequent dosing than erythromycin
|
Clarithromycin
|
|
Differs from erythromycin and clarithromycin in its long half-life (around 70 hours)
|
Azithromycin
|
|
Of the macrolides, which doesn't inhibit CYP3A4
|
Azithromycin
|
|
Inhibits CYP3A4
|
Macrolides
|
|
Macrolides adverse effects
|
CYP3A4 inhibitor, GI effects, Cholestatic hepatitis
|
|
Primary reason for stopping erythromycin
|
GI effects - epigastric distress
|
|
Fever, jaudice, impaired liver function primarily seen with erythromycin estolate dose form
|
Cholestatic hepatitis
|
|
Aerobic Gram negative bacilli are intrinsically resistant to
|
Clindamycin
|
|
Treatment of anaerobic and streptococcal and staphylococcal infections
|
Clindamycin
|
|
Drug of choice for C. perfringens
|
Clindamycin
|
|
Don't use this with erythromycin and chloramphenicol as it binds close to their binding sites
|
Clindamycin
|
|
Resistance to this drug primarily by methylation (like the macrolides)
|
Clindamycin
|
|
Adverse effects of Clindamycin
|
Severe diarrhea and Pseudomembranous colitis
|
|
Drug of choice for Vancomycin resistant Enterococcus faecium (VRE)
|
Quinupristin and dalfopristin; also linezolid/daptomycin
|
|
Quinupristin binds here:
|
At the same site as macrolides (50S)
|
|
Dalfopristin works via:
|
Directly interfers with polypeptide chain formation; synergistically enhances binding of quinupristin
|
|
Quinupristin and dalfopristin bacteriocidal or -static
|
Bacteriocidal
|
|
Adverse effects of Quinupristin and Dalfopristin
|
Infusion related events, severe arthralgias and myalgias, cost
|
|
Drug of choice for vancomycin resistant Enterococcus faecium and faecalis
|
Linezolid
|
|
Linezolid should be reserved for
|
Multi-Drug resistant Gram positives
|
|
Potent CYP3A4 inhibitor
|
Quinupristin and dalfopristin; also Macrolides
|
|
Adverse effects of Linezolid
|
Thrombocytopenia (most common), Anemia, leukopenia, cost
|
|
Mechanism of action via binding to bacterial membranes; causing rapid depolarization; loss of membrane potential; cell death
|
Daptomycin
|
|
Adverse effects of Daptomycin
|
Skeletal muscle damage, superinfection (pseudomembranous colitis), cost
|